Advanced Practitioner Society for Hematology and Oncology (APSHO) Immunotherapy (Sep, 2017)
In-Person Event
Sep 16, 2017
Rosemont, Illinois, USASpeakers
OVERVIEW
Advanced Practitioner Society for Hematology and Oncology (APSHO) Immunotherapy is organized by Advanced Practitioner Society for Hematology and Oncology (APSHO) and would be held on Sep 16, 2017 at Crowne Plaza Chicago Ohare Hotel & Conf Ctr, Rosemont, Illinois, United States of America. This CME Conference has been approved with a maximum of 5.25 AMA PRA Category 1 Credits.
Conference Objectives are :
Upon completion of this activity, participants will be able to:
• Differentiate between early and latent adverse effects associated with immunotherapeutic agents.
• Recognize the differences between the immunotherapeutic agents and of chemotherapeutic agents: mechanisms of action, adverse effects, and toxicity management.
• Describe the concept of “pseudo-progression” associated with immunotherapeutic agents and identify ways to differentiate this occurrence from real disease progression.
Why to Attend??
With new technology and scientific advances emerging all the time, oncology is a rapidly changing field. There’s no better way to keep up with these dynamics than with accredited CE. At JADPRO and APSHO, we believe in bringing accredited programs directly to you, the advanced practitioner, at that advanced level you told us you wanted. Sign up for a program near you today!
• Earn the CEs you need to keep up with your license
• Get education that’s truly at the advanced practice level
• Stay current on best practices and standards of care
• Learn from subject matter experts and your peers
• Help your team by sharing your knowledge
• Network with your colleagues and fellow advanced practitioners
• Further your career
Additional details will be posted as soon as they are available.
Conference Objectives are :
Upon completion of this activity, participants will be able to:
• Differentiate between early and latent adverse effects associated with immunotherapeutic agents.
• Recognize the differences between the immunotherapeutic agents and of chemotherapeutic agents: mechanisms of action, adverse effects, and toxicity management.
• Describe the concept of “pseudo-progression” associated with immunotherapeutic agents and identify ways to differentiate this occurrence from real disease progression.
Why to Attend??
With new technology and scientific advances emerging all the time, oncology is a rapidly changing field. There’s no better way to keep up with these dynamics than with accredited CE. At JADPRO and APSHO, we believe in bringing accredited programs directly to you, the advanced practitioner, at that advanced level you told us you wanted. Sign up for a program near you today!
• Earn the CEs you need to keep up with your license
• Get education that’s truly at the advanced practice level
• Stay current on best practices and standards of care
• Learn from subject matter experts and your peers
• Help your team by sharing your knowledge
• Network with your colleagues and fellow advanced practitioners
• Further your career
Additional details will be posted as soon as they are available.
KEY DATES
16 Sep, 2017
Event Start Date
16 Sep, 2017
Event End Date
SPECIALITIES
ImmunotherapiesSUGGESTED HOTELS
CONFERENCE VENUE
Crowne Plaza Chicago Ohare Hotel & Conf CtrRELATED CONFERENCES & LIVE WEBINARS
Quick Links